1. Arcalyst [package insert]. Tarrytown, NY: Regeneron Pharmaceuticals; September 2014.
2. Ilaris [package insert]. East Hanover, NJ: Novartis Pharmaceuticals; September 2016.
3. Hoffman, HM, Throne ML, Amar NJ, et al. Efficacy and safety of rilonacept (Interleuckin-1 Trap) in patients with cryopyrin-associated periodic syndromes. Arthritis and Rheumatism. 2008;58(8): 2443-2452.
4. Lachmann, HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360:2416-2425.
5. DRUGDEXR System [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. http://www.thomsonhc.com. Accessed May 24, 2016.
6. Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016; 75(4): 644-651.